Señales en vivo de ORIC | Maximiza tus Ganancias con Getagraph.com

COMPRAR 107871 min ago

@ $11.31

Emitido: 14 feb 2024 @ 14:07

Retorno: -24.48%

Señal anterior: feb 13 - 13:45

Señal anterior: Vender

Retorno: -1.65 %

Live Chart Being Loaded With Signals

Commentary (29 abr 2024 @ 12:59):

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States...

Stats
Volumen de hoy	144 346
Volumen promedio	570 877
Capitalización de mercado	575.79M
EPS	$0 ( 2024-03-21 )
Próxima fecha de ganancias	( $-0.440 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.36
ATR14	$0.0190 (0.22%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-06	Chacko Jacob	Sell	40 000	Common Stock
2024-02-06	Chacko Jacob	Sell	13 958	Common Stock
2024-02-07	Chacko Jacob	Sell	26 042	Common Stock
2024-01-02	Multani Pratik S	Buy	180 000	Stock Option (right to buy)
2024-01-02	Multani Pratik S	Buy	30 000	Restricted Stock Unit

INSIDER POWER
54.58
Last 99 transactions
Buy: 6 373 472 \| Sell: 3 807 004

Volumen Correlación

Largo: 0.30 (neutral)

Corto: -0.92 (very strong negative)

Signal:(58.346) Neutral

Oric Pharmaceuticals Inc Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Oric Pharmaceuticals Inc Correlación - Moneda/Commodity

0.90
( very strong )

0.95
( very strong )

0.00
( neutral )

0.83
( strong )

0.79
( moderate )

-0.80
( moderate negative )

Oric Pharmaceuticals Inc Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$-1.03M (0.00 %)
EPS:	$-1.960

FY	2023
Ingresos:	$0
Beneficio Bruto:	$-1.03M (0.00 %)
EPS:	$-1.960

FY	2022
Ingresos:	$0
Beneficio Bruto:	$-966 000 (0.00 %)
EPS:	$-2.31

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-2.07

Financial Reports:

No articles found.

Oric Pharmaceuticals Inc

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens; ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer; and ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations. The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms. It has a license and collaboration agreement with Voronoi Inc.; and a license agreement with Mirati Therapeutics, Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.